This protocol is judged by an institutional evaluate board, an independent team that testimonials any medical trials involving individuals. If a review includes a Agenda I drug, when the board approves the protocol as ethical, the scientists really have to make an application for an investigational new drug (IND) variety through the FDA.Weiser urge